细胞生物学
干细胞
造血
间充质干细胞
生物
祖细胞
内皮干细胞
骨髓
造血干细胞
Notch信号通路
血管生成
转录因子
髓样
免疫学
祖细胞
细胞分化
利基
成体干细胞
干细胞因子
信号转导
平衡
细胞
血管母细胞
作者
Chang Xu,Xue Lv,Shangda Yang,Yanling Lv,Yawei Zheng,Yu-Xiang Wang,Yan Hui,G Y Sun,Xiangnan Zhao,Lan-yue Ma,Honglin Duan,Linmin Zhang,Shuangshuang Pu,Lu Sun,Xialin Li,Yicheng He,Wenjia Fang,Meng Yang,Toshio Suda,Q Chen
出处
期刊:Blood
[Elsevier BV]
日期:2026-05-12
卷期号:148 (7): 841-855
被引量:1
标识
DOI:10.1182/blood.2025031474
摘要
ABSTRACT: Hematopoietic stem cells (HSCs) rely on specialized niche cells for their maintenance, yet how these regulators functionally integrate to preserve hematopoiesis remains unknown. In this study, we identified a subset of protein C receptor-positive (Procr+) endothelial cells (ECs) with progenitor-like properties in bone marrow (BM) which is critical for vascular homeostasis and regeneration after injury. Endothelial-specific ablation of Procr severely compromises BM vascular integrity and function. Beyond serving as a stem cell marker, Procr also serves as a functional signaling receptor in multicellular communication. Mechanistically, Procr binds heat shock protein A8 (HSPA8) to promote Foxc2 nuclear translocation, thereby upregulating delta-like ligand 4 (Dll4) transcription to sustain Dll4/Notch3 activation in mesenchymal stem cells (MSCs), revealing a Procr/HSPA8/Foxc2/Dll4 axis essential for EC and MSC cross talk. Through the HSPA8/Foxc2/Dll4/Notch3 axis, Procr+ ECs instruct MSC notch signaling, coordinating their adipogenic and osteogenic differentiation to maintain HSC self-renewal and myeloid output. Building on this mechanism, we demonstrated conserved functionality of Procr+ endothelial progenitor cells (EPCs) in human BM. Human PROCR+ ECs were found to similarly enhance DLL4/Notch3 signaling in MSCs, consequently preserving HSC function, confirming their therapeutic relevance. Our work highlights that Procr+ EPCs sustain vascular integrity and govern MSC-dependent HSC maintenance, offering targeted clinical strategies for niche regeneration.
科研通智能强力驱动
Strongly Powered by AbleSci AI